Watchlist Price Alert

Aclaris Therapeutics Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

1.24

-0.01 (-0.80%)

At close: May 13, 2025, 3:59 PM

1.30

5.26%

After-hours: May 13, 2025, 07:22 PM EDT

Aclaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	24.57M	39.88M	45.28M	27.35M	54.13M	35.94M	57.02M	208.85M	30.17M
Short-Term Investments	89.02M	79.23M	172.29M	164.06M	32.07M	39.08M	110.95M	173.66M	107.05M
Long-Term Investments	90.3M	62.77M	12.24M	34.24M	n/a	n/a	n/a	15M	36.91M
Other Long-Term Assets	3.07M	3.89M	-630K	3.55M	4.51M	4.83M	332K	279K	-35.44M
Receivables	318K	298K	484K	623K	772K	704K	563K	481K	n/a
Inventory	n/a	n/a	-12.24M	-34.24M	n/a	4.97M	791K	-6.36M	n/a
Other Current Assets	12.04M	9.45M	13.49M	12.99M	2.59M	6.72M	5.37M	5.88M	1.33M
Total Current Assets	125.95M	128.86M	231.55M	205.03M	57.49M	83.8M	179.5M	208.85M	174.13M
Property-Plant & Equipment	1.01M	1.62M	1.1M	1.33M	1.65M	2.47M	4.28M	2.16M	481K
Goodwill & Intangibles	n/a	269K	6.97M	7.05M	7.12M	7.2M	91.45M	25.85M	n/a
Total Long-Term Assets	94.38M	68.55M	23.05M	46.18M	13.29M	14.49M	96.07M	34.66M	1.95M
Total Assets	220.33M	197.41M	254.6M	251.21M	70.78M	98.3M	275.57M	243.51M	176.09M
Account Payables	4.69M	8.88M	10.35M	9.98M	5.25M	9.92M	11.68M	7.82M	2.85M
Deferred Revenue	3.89M	n/a	n/a	10.05M	5.91M	7.72M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	684K	693K	603K	637K	n/a	n/a	n/a
Other Current Liabilities	23.02M	10.79M	6.81M	4.52M	4.44M	6.84M	7.44M	n/a	100K
Total Current Liabilities	31.6M	30.95M	21.94M	22.93M	14.87M	22.43M	27.34M	12.76M	6.22M
Long-Term Debt	n/a	n/a	n/a	n/a	10.65M	n/a	29.91M	n/a	n/a
Other Long-Term Liabilities	33.18M	9.27M	34.67M	30.57M	7.24M	5.4M	2.64M	4.94M	372K
Total Long-Term Liabilities	33.18M	9.27M	35.04M	30.94M	18.26M	5.95M	33.1M	5.49M	372K
Total Liabilities	64.77M	40.23M	56.98M	53.87M	33.13M	28.39M	60.44M	18.25M	6.59M
Total Debt	n/a	426K	684K	693K	11.26M	637K	30.52M	142K	n/a
Common Stock	1K	1K	1K	1K	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-902.86M	-770.8M	-682.32M	-595.41M	-504.54M	-453.53M	-292.17M	-159.44M	-90.91M
Comprehensive Income	97K	-106K	-897K	-224K	-94K	-66K	-69K	-246K	-269K
Shareholders Equity	155.55M	157.18M	197.62M	197.34M	37.65M	69.91M	215.12M	225.26M	169.49M
Total Investments	179.33M	142M	184.54M	198.31M	32.07M	39.08M	110.95M	188.65M	143.96M